Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-011383
Filing Date
2023-04-18
Accepted
2023-04-18 17:10:09
Documents
2
Period of Report
2023-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1565
2 EX-24 DOCUMENT attachment1.htm EX-24 3865
  Complete submission text file 0000899243-23-011383.txt   6769
Mailing Address 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807
Business Address
Rosiello Robert L. (Reporting) CIK: 0001645041 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38473 | Film No.: 23827688

Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

EIN.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations